|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0006041,
umls-concept:C0011065,
umls-concept:C0035647,
umls-concept:C0085436,
umls-concept:C0087111,
umls-concept:C0205216,
umls-concept:C0205265,
umls-concept:C0332281,
umls-concept:C0887947,
umls-concept:C1524063,
umls-concept:C1555582
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-9-29
|
|
pubmed:abstractText |
The objective of this study was to evaluate outcomes among adults with a first episode of cryptococcal meningitis (CM), comparing those on highly active antiretroviral therapy (HAART) with those not on HAART.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
227-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18769344-Adult,
pubmed-meshheading:18769344-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18769344-Botswana,
pubmed-meshheading:18769344-Cohort Studies,
pubmed-meshheading:18769344-Female,
pubmed-meshheading:18769344-HIV Infections,
pubmed-meshheading:18769344-Humans,
pubmed-meshheading:18769344-Logistic Models,
pubmed-meshheading:18769344-Male,
pubmed-meshheading:18769344-Meningitis, Cryptococcal,
pubmed-meshheading:18769344-Middle Aged,
pubmed-meshheading:18769344-Prospective Studies,
pubmed-meshheading:18769344-Risk Factors,
pubmed-meshheading:18769344-Survival Analysis
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana.
|
|
pubmed:affiliation |
Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA. gregbisson@mac.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, N.I.H., Intramural
|
